Abstract
Ozgene is a commercial venture established to produce genetically modified mice (GM-mice). GM-mice are the most sophisticated tools in functional genomics and drug target validation. Our Directors, CEO and COO provide internationally recognized expertise to produce GM-mice for the biotechnology & pharmaceutical industry and academic institutions.
Ozgene’s service includes the identification, isolation, sequencing and mapping of murine genes followed by the generation of classical or conditional knock-outs, knock-ins and transgenics.
We also offer phenotypic analysis of GM-mice; providing a complete service from gene discovery to gene function.
We are able to produce, supply, maintain and cryopreserve GM-mice in alliance with the Animal Resources Centre, Australia’s premier supplier of specific pathogen free (SPF) laboratory animals.
Ozgene’s senior management team has an established track record in the generation and analysis of GM-mice as published in leading scientific journals including Nature, Science, EMBO, PNAS. Our CEO and COO were amongst the first to produce C57BL/6 knock-out mice and NOD transgenic mice.
The abstracts were prepared by Professor Jegan Krishnan. Correspondence should be addressed to him at the Flinders Medical Centre, Bedford Park 5047, Australia.
